Rapid and sensitive HPLC-MS/MS method for quantitative determination of isochlorogenic acid B in rat plasma and its application in pharmacokinetic study

doi:10.5246/jcps.2019.03.016

Journal of Chinese Pharmaceutical Sciences ›› 2019, Vol. 28 ›› Issue (3): 167-173.DOI: 10.5246/jcps.2019.03.016

• Original articles • Previous Articles Next Articles

Rapid and sensitive HPLC-MS/MS method for quantitative determination of isochlorogenic acid B in rat plasma and its application in pharmacokinetic study

Xin Liu^1,2, Bo Zhang¹, Dan Mei¹, Kai Huang^3*

1. Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
3. Drug Clinical Trial Institution, Wuxi People’ Hospital, Nanjing Medical University, Wuxi 214023, China

Received:2018-12-30 Revised:2019-01-05 Online:2019-03-30 Published:2019-02-17
Contact: Tel.: +86-010-85350347, E-mail: hk19820627@sina.com
Supported by:
Chinese Academy of Medical Sciences (Grant No. CAMS-2017-I2M-1-011).

Abstract

Abstract:

Asensitive LC-ESI-MS/MS method for determination of isochlorogenic acid B in rat plasma was developed and validated in the present study. Plasma samples were prepared by a simple protein precipitation with methanol containing resveratrol as internal standard (IS). The chromatographic separation was performed on a Zorbax SB-C₁₈column (3.5 μm, 2.1 mm×100 mm, Agilent, USA) at a flow rate of 0.2 mL/min using methanol/water containing 0.1% formic acid (v/v) as mobile phase. The detectionwas performed on a triple quadrupole tandem mass spectrometer equipped with Electronic Spray Ion by selected reaction monitoring (SRM) of the transitions at m/z 515.3→352.9 for isochlorogenic acid B and m/z 227.1→143.1 for IS, respectively. The calibration curve of the method was linear over the range of 5–2500 ng/mL (r²= 0.9982). The intra- and inter-day precisions (R.S.D.%) were less than 12.46%, and the accuracy (R.E.%) was within ±5.80%. Isochlorogenic acid B was sufficiently stable under all relevant analytical conditions. The validated method was successfully applied to the plasma pharmacokinetic studies of isochlorogenic acid B in rats. It was found that isochlorogenic acid B had non-linear pharmacokinetic characteristics in rats within the dosage ranges from 5 to 20 mg/kg.

Key words: Isochlorogenic acid B, LC-ESI-MS/MS, Plasma concentration, Pharmacokinetics

CLC Number:

R969.1

Supporting:

Xin Liu, Bo Zhang, Dan Mei, Kai Huang. Rapid and sensitive HPLC-MS/MS method for quantitative determination of isochlorogenic acid B in rat plasma and its application in pharmacokinetic study[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(3): 167-173.

References

[1] Wu, Y.H.; Yang, L.X.; Wang, F.; Wu, X.M.; Zhou, C.X.; Shi, S.Y.; Mo, J.X.; Zhao, Y. Hepatoprotective and antioxidative effects of total phenolics from Laggera pterodonta on chemical-induced injury in primary cultured neonatal rat hepatocytes. Food Chem. Toxicol. 2007, 45, 1349-1355.

[2] Wu, Y.H.; Zhang, X.M.; Hu, M.H.; Wu, X.M.; Zhao, Y. Effect of Laggera alata on hepatocyte damage induced by carbon tetrachloride in vitro and in vivo. J. Ethnopharmacol. 2009, 126, 50-56.

[3] Wu, Y.H.; Wang, F.; Zheng, Q.X.; Lu, L.X.; Yao, H.T.; Zhou, C.X.; Wu, X.M.; Zhao, Y. Hepatoprotective effect of total flavonoids from Laggera alata against carbon tetrachloride-induced injury in primary cultured neonatal rat hepatocytes and in rats with hepatic damage. J. Biomed. Sci. 2006, 13, 569-578.

[4] Ma, Y.C.; Wang, X.Q.; Hou, F.F.; Ma, J.; Luo, M.; Chen, A.; Jin, P.; Lu, S.N.; Xu, I. Rapid resolution liquid chromatography (RRLC) analysis and studies on the stability of Shuang-Huang-Lian preparations. J. Pharm. Biomed. Anal. 2011, 54, 265-272.

[5] Han, J.; Ye, M.; Guo, H.; Yang, M.; Wang, B.R.; Guo, D.A. Analysis of multiple constituents in a Chinese herbal preparation Shuang-Huang-Lian oral liquid by HPLC-DAD-ESI-MSn. J Pharm Biomed Anal. 2007, 44, 430-438.

[6] Chang, Y.X.; Liu, J.; Bai, Y.; Li, J.; Liu, E.W.; He, J.; Jiao, X.C.; Wang, Z.Z.; Gao, X.M.; Zhang, B.L.; Xiao, W. The Activity-Integrated Method for Quality Assessment of Reduning Injection by On-Line DPPH-CE-DAD. PLoS One. 2014, 9, e106254.

[7] Sroka, Z.; Cisowski, W. Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food & Chem. Toxicol. 2003, 41, 753-758.

[8] Im, S.E.; Yoon, H.; Nam, T.G.; Heo, H.J.; Lee, C.Y.; Kim, D.O. Antineurodegenerative effect of phenolic extracts and caffeic acid derivatives in romaine lettuce on neuron-like PC-12 cells. J. Med. Food. 2010, 13, 779-784.

[9] Choi, J.; Park, J.K.; Lee, K.T.; Park, K.K.; Kim, W.B.; Lee, J.H.; Jung, H.J.; Park, H.J. In vivo antihepatotoxic effects of Ligularia fischeri var. spiciformis and the identification of the active component, 3,4-dicaffeoylquinic acid. J. Med. Food. 2005, 8, 348-352.

[10] Wu, Y.H.; Hao, B.J.; Shen, E.; Meng, Q.L.; Hu, M.H.; Zhao, Y. Protective Properties of Laggera alata Extract and its Principle Components Against d-Galactosamine-Injured Hepatocytes. Sci. Pharm. 2012, 80, 447-456.

[11] Xu, J.G.; Hu, Q.P.; Liu, Y. Antioxidant and DNA-protective activities of chlorogenic acid isomers. J. Agric. Food Chem. 2012, 60, 11625-11630.

[12] Liu, X.; Huang, K.; Niu, Z. R.; Mei, D.; Zhang, B. Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice. Basic Clin. Pharmacol. Toxicol. 2019, 124, 144-153.

[1]	Yanfang Yang, Wei Wei, Lei Zhang, Wei Xu, Xiuwei Yang. Simultaneous quantification of 37 constituents in Duliang Pill by UPLC-MS/MS: Application to the pharmacokinetic studies in rat plasma [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 560-573.
[2]	Yingyuan Lu, Mei Zhang, Shengju Yin, Xiaona Dong, Zhiyuan Zhang, Haixu Cheng, Pengfei Tu, Guifang Dou, Yongsheng Che, Zhenghui Xu, Feng Xu, Xian Wang, Chuang Lu, Yaqing Lou, Guoliang Zhang. Epigenetic variants of xenobiotic metabolism affect individual differences in antiepileptic drug 3,4-DCPB pharmacokinetic phenotype [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(1): 1-16.
[3]	Yanan Li, Xue Guo, Ye Yuan, Weichong Dong, Xiuling Yang. Determination of free ceftriaxone concentration and its application in predicting lung tissue concentration [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(7): 578-589.
[4]	Xiaojiao Li, Shuxin Luan, Hong Zhang, Hongquan Wan, Hong Chen, Chengjiao Liu, Chang Liu, Yanhua Ding. Pharmacokinetics, pharmacodynamics and safety of a single-dose long-acting Risperidone injection in Chinese patients with schizophrenia [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(3): 206-217.
[5]	Yan Zhou, Hengwen Song, Zhichao Shao, Bomin Yin, Ximei Fu, Dianyou Xie, Lijun Wei. Preclinical efficacy of a novel cyclin-dependent kinase 9 inhibitor, QHRD107 against acute myeloid leukemia [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(2): 146-156.
[6]	Ye Yuan, Bo Yu, Xueqin Zhang, Yanan Li, Shumei Wang. Effects of Zhenyuan capsule on the pharmacokinetics comparison of simvastatin and its active metabolites in rats [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(7): 494-503.
[7]	Jin Zhang, Weiwei Lin, Wei Wu, Xianzhong Guo, Pinfang Huang, Xinhua Lin, Zheng Jiao, Changlian Wang. Population pharmacokinetics of vancomycin in Chinese elderly patients and its application for dose individualisation [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(4): 260-271.
[8]	Xinyu Chang, Tao Guo, Guiming Guo . Effect of CYP3A4 genetic polymorphisms on pharmacokinetics of tinidazole [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(4): 272-279.
[9]	Shengxin Wang, Xiangli Yan, Haozhen Zheng, Jianye Yu, Aiming Yu, Xiao Shen, Lisheng Wang. Pharmacokinetics of different dosage of astragalus membranaceus of buyang huanwu decoction in rats with cerebral ischemic injury by microdialysis combined with LC/MS [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(2): 90-101.
[10]	Jingjing Cao, Jun Sun, Shujuan Zhao, Peizhi Ma. Pharmacological and clinical evaluation of a new anti-flu drug, baloxavir marboxil [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(10): 729-733.
[11]	Xiwei Ji, Zisheng Kang, Yun Li, Xiping Yang, Xifeng Ma, Chongtie Shi, Yuan Lv. An established LC-MS/MS method and a developed PK model for the study of pharmacokinetic properties of benapenem in infected mice [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(11): 802-811.
[12]	Lingling Zhang, Huiwen Zhang, Shikui Wu, Hong Liu, Jingyuan Li, Xin Dong, Huimin Xia, Huanyun Wang. Simultaneous determination of the pharmacokinetics of the active components of San-Chen-pill by UPLC-Q-Exactive-MS [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(11): 812-824.
[13]	Wenjuan OuYang, Yalan Zhang, Pingsheng Xu, Zhiyong Dai, Hongying Ma, Qun Qin. Pharmacokinetics of Pazufloxacin Mesilate Sodium Chloride in healthy Chinese volunteers after intravenous injection [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(1): 40-48.
[14]	Yan Cai, Wei Dai, Fuhua Qin, Jieyin Sun, Ruilong Wei. Genistein-loaded poloxamer 403/407 mixed micelles: preparation and pharmacokinetic study in rats [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 342-351.
[15]	Xinyu Chang, Guiming Guo, Zheng Fan, Honglei Wang, Yang Liu, Lijuan Han. Simultaneous determination of two bioactive components of Huangqi Guizhi Wuwu Decoction in rat plasma using UPLC-MS/MS and its application to a pharmacokinetic study [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(4): 263-272.

Rapid and sensitive HPLC-MS/MS method for quantitative determination of isochlorogenic acid B in rat plasma and its application in pharmacokinetic study

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments